Kurepen 625 Tablet is a combination antibiotic formulation containing Amoxycillin 500 mg and Clavulanic Acid 125 mg, designed to treat a broad spectrum of bacterial infections. Amoxycillin, a beta-lactam antibiotic, exerts its bactericidal effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Amoxycillin by preventing enzymatic degradation of the antibiotic by beta-lactamase-producing bacteria, thereby extending its spectrum of activity. Kurepen 625 is indicated for the treatment of infections caused by susceptible strains of bacteria including respiratory tract infections (such as sinusitis, bronchitis, and pneumonia), urinary tract infections, skin and soft tissue infections, and otitis media. It is also effective against certain dental infections and bone and joint infections. The tablet is administered orally, with dosage and duration tailored according to the severity of infection and patient-specific factors. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Hypersensitivity reactions, including rash and anaphylaxis, although rare, require immediate medical attention. Kurepen 625 should be used cautiously in patients with a history of penicillin allergy and renal impairment. Proper adherence to prescribed therapy is essential to prevent antibiotic resistance.

Dosage & How to Use